| NITTA GELATIN INC. Patent applications |
| Patent application number | Title | Published |
|---|
| 20110210517 | Sealing material and method of foaming application thereof - Objective problems of the present invention are: to provide a sealing material which does not involve flowing after applied, and shows an excellent sealing performance even under severe heat resistance conditions, and also can make good independent cells inside even when used in a foamed condition; and to provide a method of foaming application of the sealing material. As means of solving these objective problems, the sealing material according to the present invention is characterized by comprising an ultraviolet-curable component and an ultraviolet polymerization initiator and having a thermoplastic elastomer (which is not ultraviolet-curable) content of not higher than 5 weight % and comprising an acrylate as the ultraviolet-curable component and having a melt-viscosity at 120° C. in a certain range wherein the acrylate has a glass transition temperature after ultraviolet curing and a weight-average molecular weight in their respective certain ranges; and the method according to the present invention of foaming application of a sealing material is characterized by comprising the steps of: hot-melting the sealing material; mixing nitrogen gas into the melted sealing material under a predefined pressurization; discharging the resultant mixture at a predefined pressure into the air to thus foam the mixture and simultaneously apply it to a place necessary to seal, thus making a sealing foam; and curing this sealing foam by ultraviolet rays. | 09-01-2011 |
| 20110166365 | Collagen peptide, dipeptide and malady inhibitor - A problem that the present invention is to solve is to provide: a main body of a peptide molecule which is effective for inhibition of various maladies such as osteoporosis, osteoarthritis and pressure ulcer, particularly, a dipeptide which is easy to absorb into a body in an intestine; a collagen peptide which comprises the dipeptide as an essential dipeptide; and a malady inhibitor which comprises the dipeptide as an essential effective component. As a means of solving such a problem, a collagen peptide according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential dipeptide. A dipeptide according to the present invention is characterized by having a structure of Hyp-Gly. A malady inhibitor according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential effective component. | 07-07-2011 |
